Human Genome Epidemiology Literature Finder
Filtered By: |
Previous |
Records 1 - 7 (of 7 Records) |
Query Trace: Breast Neoplasms and meta-analysis and MTRR[original query] |
---|
MTRR A66G polymorphism and breast cancer risk: a meta-analysis. Breast cancer research and treatment 2010 Dec 124 (3): 779-84. Hu Jia, Zhou Guo-Wu, Wang Ning, Wang Ya-J |
Methionine synthase reductase A66G polymorphism contributes to tumor susceptibility: evidence from 35 case-control studies. Molecular biology reports 2011 May . Han D, Shen C, Meng X, Bai J, Chen F, Yu Y, Jin Y, Fu S |
Polymorphisms in the folate-metabolizing genes MTR, MTRR, and CBS and breast cancer risk. Cancer epidemiology 2012 Apr 36 (2): e95-e100. Weiner Alexandra S, Boyarskikh Uljana A, Voronina Elena N, Selezneva Inna A, Sinkina Tatiana V, Lazarev Alexandr F, Petrova Valentina D, Filipenko Maxim |
Methionine synthase reductase A66G polymorphism is not associated with breast cancer susceptibility - a meta-analysis. Asian Pacific journal of cancer prevention : APJCP 2014 15 (7): 3267-71. Hu Shu, Liu Hong-Chao, Xi Shou-Mi |
Associations between folate metabolism enzyme polymorphisms and breast cancer: A meta-analysis. The breast journal 2019 Sep . Mo Wenju, Ding Yuqin, Zheng Yurong, Zou Dehong, Ding Xiaow |
Post genome-wide gene-environment interaction study: The effect of genetically driven insulin resistance on breast cancer risk using Mendelian randomization. PloS one 2019 14 (6): e0218917. Jung Su Yon, Mancuso Nicholas, Papp Jeanette, Sobel Eric, Zhang Zuo-Fe |
A meta-analysis and in silico analysis of polymorphic variants conferring breast cancer risk in the Indian subcontinent. Future oncology (London, England) 2020 8 16 (27): 2121-2142. Sengupta Debmalya, Banerjee Souradeep, Mukhopadhyay Pramiti, Guha Udayan, Ganguly Kausik, Bhattacharjee Samsiddhi, Sengupta Main |
- Page last reviewed:Feb 1, 2024
- Content source: